nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlodipine—CYP2B6—Thiotepa—urinary bladder cancer	0.104	0.194	CbGbCtD
Amlodipine—ABCB1—Mitomycin—urinary bladder cancer	0.0706	0.131	CbGbCtD
Amlodipine—CYP2A6—Fluorouracil—urinary bladder cancer	0.0521	0.0966	CbGbCtD
Amlodipine—CYP3A4—Thiotepa—urinary bladder cancer	0.0321	0.0595	CbGbCtD
Amlodipine—CYP2B6—Cisplatin—urinary bladder cancer	0.0288	0.0534	CbGbCtD
Amlodipine—CYP2C8—Fluorouracil—urinary bladder cancer	0.0257	0.0476	CbGbCtD
Amlodipine—CYP3A5—Etoposide—urinary bladder cancer	0.0223	0.0413	CbGbCtD
Amlodipine—CYP2C8—Etoposide—urinary bladder cancer	0.0214	0.0397	CbGbCtD
Amlodipine—ABCB1—Gemcitabine—urinary bladder cancer	0.0203	0.0377	CbGbCtD
Amlodipine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0199	0.0369	CbGbCtD
Amlodipine—CYP2B6—Doxorubicin—urinary bladder cancer	0.0193	0.0358	CbGbCtD
Amlodipine—CYP2C9—Fluorouracil—urinary bladder cancer	0.0179	0.0332	CbGbCtD
Amlodipine—CYP1A2—Etoposide—urinary bladder cancer	0.0166	0.0308	CbGbCtD
Amlodipine—CYP2C9—Cisplatin—urinary bladder cancer	0.0152	0.0282	CbGbCtD
Amlodipine—ABCB1—Cisplatin—urinary bladder cancer	0.0148	0.0274	CbGbCtD
Amlodipine—ABCB1—Etoposide—urinary bladder cancer	0.0145	0.0269	CbGbCtD
Amlodipine—SMPD1—urine—urinary bladder cancer	0.0119	0.11	CbGeAlD
Amlodipine—ABCB1—Doxorubicin—urinary bladder cancer	0.0099	0.0183	CbGbCtD
Amlodipine—ABCB1—Methotrexate—urinary bladder cancer	0.00959	0.0178	CbGbCtD
Amlodipine—CYP2D6—Doxorubicin—urinary bladder cancer	0.00933	0.0173	CbGbCtD
Amlodipine—CYP3A4—Etoposide—urinary bladder cancer	0.0087	0.0161	CbGbCtD
Amlodipine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00593	0.011	CbGbCtD
Amlodipine—CACNA2D3—prostate gland—urinary bladder cancer	0.00567	0.0523	CbGeAlD
Amlodipine—CACNA2D3—seminal vesicle—urinary bladder cancer	0.0048	0.0442	CbGeAlD
Amlodipine—SMPD1—prostate gland—urinary bladder cancer	0.00428	0.0395	CbGeAlD
Amlodipine—CACNA1S—seminal vesicle—urinary bladder cancer	0.00414	0.0381	CbGeAlD
Amlodipine—CACNA2D3—urethra—urinary bladder cancer	0.0038	0.035	CbGeAlD
Amlodipine—CYP1A2—urine—urinary bladder cancer	0.00337	0.0311	CbGeAlD
Amlodipine—CYP2C9—urine—urinary bladder cancer	0.0032	0.0295	CbGeAlD
Amlodipine—CACNB2—prostate gland—urinary bladder cancer	0.00294	0.0271	CbGeAlD
Amlodipine—SMPD1—renal system—urinary bladder cancer	0.00292	0.0269	CbGeAlD
Amlodipine—CACNA2D3—vagina—urinary bladder cancer	0.0028	0.0258	CbGeAlD
Amlodipine—CACNA2D1—prostate gland—urinary bladder cancer	0.00276	0.0255	CbGeAlD
Amlodipine—CACNA1D—prostate gland—urinary bladder cancer	0.00257	0.0237	CbGeAlD
Amlodipine—CYP3A4—urine—urinary bladder cancer	0.00244	0.0225	CbGeAlD
Amlodipine—CYP2D6—urine—urinary bladder cancer	0.0024	0.0221	CbGeAlD
Amlodipine—CACNA1C—prostate gland—urinary bladder cancer	0.00237	0.0219	CbGeAlD
Amlodipine—SMPD1—female reproductive system—urinary bladder cancer	0.00234	0.0216	CbGeAlD
Amlodipine—CYP2A6—prostate gland—urinary bladder cancer	0.0023	0.0212	CbGeAlD
Amlodipine—SMPD1—vagina—urinary bladder cancer	0.00212	0.0195	CbGeAlD
Amlodipine—CYP2A6—seminal vesicle—urinary bladder cancer	0.00195	0.018	CbGeAlD
Amlodipine—CACNA2D3—lymph node—urinary bladder cancer	0.00181	0.0167	CbGeAlD
Amlodipine—CACNA1B—lymph node—urinary bladder cancer	0.0017	0.0157	CbGeAlD
Amlodipine—CACNA1C—smooth muscle tissue—urinary bladder cancer	0.00168	0.0155	CbGeAlD
Amlodipine—CACNB2—vagina—urinary bladder cancer	0.00145	0.0134	CbGeAlD
Amlodipine—CA1—renal system—urinary bladder cancer	0.00143	0.0132	CbGeAlD
Amlodipine—SMPD1—lymph node—urinary bladder cancer	0.00137	0.0126	CbGeAlD
Amlodipine—CACNA2D1—vagina—urinary bladder cancer	0.00136	0.0126	CbGeAlD
Amlodipine—CACNA1C—female reproductive system—urinary bladder cancer	0.00129	0.0119	CbGeAlD
Amlodipine—CACNA1C—vagina—urinary bladder cancer	0.00117	0.0108	CbGeAlD
Amlodipine—CYP3A5—prostate gland—urinary bladder cancer	0.00117	0.0108	CbGeAlD
Amlodipine—CA1—female reproductive system—urinary bladder cancer	0.00114	0.0105	CbGeAlD
Amlodipine—CYP2A6—vagina—urinary bladder cancer	0.00114	0.0105	CbGeAlD
Amlodipine—CACNB2—lymph node—urinary bladder cancer	0.000939	0.00866	CbGeAlD
Amlodipine—CACNA2D1—lymph node—urinary bladder cancer	0.000882	0.00813	CbGeAlD
Amlodipine—CYP2C8—renal system—urinary bladder cancer	0.000881	0.00813	CbGeAlD
Amlodipine—CYP1A1—epithelium—urinary bladder cancer	0.000877	0.00809	CbGeAlD
Amlodipine—CYP1A2—renal system—urinary bladder cancer	0.000825	0.0076	CbGeAlD
Amlodipine—CACNA1D—lymph node—urinary bladder cancer	0.000821	0.00757	CbGeAlD
Amlodipine—CYP1A1—renal system—urinary bladder cancer	0.000814	0.0075	CbGeAlD
Amlodipine—CYP1A1—urethra—urinary bladder cancer	0.000799	0.00737	CbGeAlD
Amlodipine—CYP3A5—renal system—urinary bladder cancer	0.000796	0.00733	CbGeAlD
Amlodipine—CYP2B6—renal system—urinary bladder cancer	0.000791	0.00729	CbGeAlD
Amlodipine—CACNA1C—lymph node—urinary bladder cancer	0.000758	0.00698	CbGeAlD
Amlodipine—CYP2C8—female reproductive system—urinary bladder cancer	0.000706	0.00651	CbGeAlD
Amlodipine—CA1—lymph node—urinary bladder cancer	0.000669	0.00617	CbGeAlD
Amlodipine—CYP1A1—female reproductive system—urinary bladder cancer	0.000652	0.00601	CbGeAlD
Amlodipine—CYP2C8—vagina—urinary bladder cancer	0.000638	0.00589	CbGeAlD
Amlodipine—CYP2B6—female reproductive system—urinary bladder cancer	0.000633	0.00584	CbGeAlD
Amlodipine—CYP2C9—female reproductive system—urinary bladder cancer	0.000627	0.00578	CbGeAlD
Amlodipine—ABCB1—prostate gland—urinary bladder cancer	0.00062	0.00572	CbGeAlD
Amlodipine—CYP3A4—renal system—urinary bladder cancer	0.000597	0.0055	CbGeAlD
Amlodipine—CYP1A1—vagina—urinary bladder cancer	0.000589	0.00543	CbGeAlD
Amlodipine—CYP2D6—renal system—urinary bladder cancer	0.000588	0.00542	CbGeAlD
Amlodipine—CYP3A5—vagina—urinary bladder cancer	0.000576	0.00531	CbGeAlD
Amlodipine—CYP2B6—vagina—urinary bladder cancer	0.000573	0.00528	CbGeAlD
Amlodipine—ABCB1—seminal vesicle—urinary bladder cancer	0.000524	0.00483	CbGeAlD
Amlodipine—CYP3A4—female reproductive system—urinary bladder cancer	0.000478	0.00441	CbGeAlD
Amlodipine—CYP2D6—female reproductive system—urinary bladder cancer	0.000471	0.00434	CbGeAlD
Amlodipine—ABCB1—epithelium—urinary bladder cancer	0.000456	0.0042	CbGeAlD
Amlodipine—ABCB1—renal system—urinary bladder cancer	0.000423	0.0039	CbGeAlD
Amlodipine—ABCB1—urethra—urinary bladder cancer	0.000415	0.00383	CbGeAlD
Amlodipine—CYP1A1—lymph node—urinary bladder cancer	0.000381	0.00351	CbGeAlD
Amlodipine—ABCB1—female reproductive system—urinary bladder cancer	0.000338	0.00312	CbGeAlD
Amlodipine—ABCB1—vagina—urinary bladder cancer	0.000306	0.00282	CbGeAlD
Amlodipine—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.0002	0.00101	CcSEcCtD
Amlodipine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000199	0.001	CcSEcCtD
Amlodipine—Pruritus—Fluorouracil—urinary bladder cancer	0.000198	0.000999	CcSEcCtD
Amlodipine—ABCB1—lymph node—urinary bladder cancer	0.000198	0.00183	CbGeAlD
Amlodipine—Visual impairment—Methotrexate—urinary bladder cancer	0.000198	0.000996	CcSEcCtD
Amlodipine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000196	0.000986	CcSEcCtD
Amlodipine—Bradycardia—Epirubicin—urinary bladder cancer	0.000195	0.000985	CcSEcCtD
Amlodipine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000195	0.000983	CcSEcCtD
Amlodipine—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000194	0.000978	CcSEcCtD
Amlodipine—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000194	0.000978	CcSEcCtD
Amlodipine—Urticaria—Etoposide—urinary bladder cancer	0.000193	0.000974	CcSEcCtD
Amlodipine—Haemoglobin—Epirubicin—urinary bladder cancer	0.000193	0.000972	CcSEcCtD
Amlodipine—Jaundice—Doxorubicin—urinary bladder cancer	0.000193	0.000972	CcSEcCtD
Amlodipine—Rhinitis—Epirubicin—urinary bladder cancer	0.000192	0.00097	CcSEcCtD
Amlodipine—Abdominal pain—Etoposide—urinary bladder cancer	0.000192	0.000969	CcSEcCtD
Amlodipine—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000192	0.000969	CcSEcCtD
Amlodipine—Haemorrhage—Epirubicin—urinary bladder cancer	0.000192	0.000968	CcSEcCtD
Amlodipine—Hepatitis—Epirubicin—urinary bladder cancer	0.000192	0.000968	CcSEcCtD
Amlodipine—Eye disorder—Methotrexate—urinary bladder cancer	0.000192	0.000966	CcSEcCtD
Amlodipine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000192	0.000966	CcSEcCtD
Amlodipine—Tinnitus—Methotrexate—urinary bladder cancer	0.000191	0.000964	CcSEcCtD
Amlodipine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000191	0.000963	CcSEcCtD
Amlodipine—Asthenia—Cisplatin—urinary bladder cancer	0.000191	0.00096	CcSEcCtD
Amlodipine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.00019	0.00096	CcSEcCtD
Amlodipine—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.00019	0.000955	CcSEcCtD
Amlodipine—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000189	0.000953	CcSEcCtD
Amlodipine—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000189	0.000951	CcSEcCtD
Amlodipine—Urethral disorder—Epirubicin—urinary bladder cancer	0.000188	0.000948	CcSEcCtD
Amlodipine—Epistaxis—Doxorubicin—urinary bladder cancer	0.000187	0.000941	CcSEcCtD
Amlodipine—Angiopathy—Methotrexate—urinary bladder cancer	0.000186	0.000938	CcSEcCtD
Amlodipine—Immune system disorder—Methotrexate—urinary bladder cancer	0.000185	0.000934	CcSEcCtD
Amlodipine—Dizziness—Fluorouracil—urinary bladder cancer	0.000185	0.000934	CcSEcCtD
Amlodipine—Visual impairment—Epirubicin—urinary bladder cancer	0.000185	0.000932	CcSEcCtD
Amlodipine—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000185	0.000932	CcSEcCtD
Amlodipine—Chills—Methotrexate—urinary bladder cancer	0.000184	0.000928	CcSEcCtD
Amlodipine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000182	0.000916	CcSEcCtD
Amlodipine—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000182	0.000915	CcSEcCtD
Amlodipine—Alopecia—Methotrexate—urinary bladder cancer	0.000181	0.000914	CcSEcCtD
Amlodipine—Vomiting—Gemcitabine—urinary bladder cancer	0.000181	0.000913	CcSEcCtD
Amlodipine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000181	0.000911	CcSEcCtD
Amlodipine—Mental disorder—Methotrexate—urinary bladder cancer	0.00018	0.000906	CcSEcCtD
Amlodipine—Rash—Gemcitabine—urinary bladder cancer	0.00018	0.000905	CcSEcCtD
Amlodipine—Dermatitis—Gemcitabine—urinary bladder cancer	0.00018	0.000905	CcSEcCtD
Amlodipine—Eye disorder—Epirubicin—urinary bladder cancer	0.000179	0.000904	CcSEcCtD
Amlodipine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000179	0.000903	CcSEcCtD
Amlodipine—Tinnitus—Epirubicin—urinary bladder cancer	0.000179	0.000902	CcSEcCtD
Amlodipine—Malnutrition—Methotrexate—urinary bladder cancer	0.000179	0.0009	CcSEcCtD
Amlodipine—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000179	0.0009	CcSEcCtD
Amlodipine—Headache—Gemcitabine—urinary bladder cancer	0.000179	0.0009	CcSEcCtD
Amlodipine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000178	0.000898	CcSEcCtD
Amlodipine—Flushing—Epirubicin—urinary bladder cancer	0.000178	0.000898	CcSEcCtD
Amlodipine—Vomiting—Fluorouracil—urinary bladder cancer	0.000178	0.000898	CcSEcCtD
Amlodipine—Rhinitis—Doxorubicin—urinary bladder cancer	0.000178	0.000898	CcSEcCtD
Amlodipine—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000178	0.000895	CcSEcCtD
Amlodipine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000178	0.000895	CcSEcCtD
Amlodipine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000177	0.000891	CcSEcCtD
Amlodipine—Rash—Fluorouracil—urinary bladder cancer	0.000177	0.00089	CcSEcCtD
Amlodipine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000176	0.000889	CcSEcCtD
Amlodipine—Headache—Fluorouracil—urinary bladder cancer	0.000176	0.000885	CcSEcCtD
Amlodipine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000175	0.000884	CcSEcCtD
Amlodipine—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000175	0.000882	CcSEcCtD
Amlodipine—Dysgeusia—Methotrexate—urinary bladder cancer	0.000175	0.000881	CcSEcCtD
Amlodipine—Asthenia—Etoposide—urinary bladder cancer	0.000175	0.00088	CcSEcCtD
Amlodipine—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000175	0.00088	CcSEcCtD
Amlodipine—Angiopathy—Epirubicin—urinary bladder cancer	0.000174	0.000878	CcSEcCtD
Amlodipine—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000174	0.000878	CcSEcCtD
Amlodipine—Immune system disorder—Epirubicin—urinary bladder cancer	0.000173	0.000874	CcSEcCtD
Amlodipine—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000173	0.000872	CcSEcCtD
Amlodipine—Back pain—Methotrexate—urinary bladder cancer	0.000173	0.000871	CcSEcCtD
Amlodipine—Chills—Epirubicin—urinary bladder cancer	0.000172	0.000868	CcSEcCtD
Amlodipine—Pruritus—Etoposide—urinary bladder cancer	0.000172	0.000868	CcSEcCtD
Amlodipine—Arrhythmia—Epirubicin—urinary bladder cancer	0.000172	0.000864	CcSEcCtD
Amlodipine—Visual impairment—Doxorubicin—urinary bladder cancer	0.000171	0.000863	CcSEcCtD
Amlodipine—Alopecia—Epirubicin—urinary bladder cancer	0.00017	0.000855	CcSEcCtD
Amlodipine—Nausea—Gemcitabine—urinary bladder cancer	0.000169	0.000853	CcSEcCtD
Amlodipine—Vomiting—Cisplatin—urinary bladder cancer	0.000169	0.000851	CcSEcCtD
Amlodipine—Mental disorder—Epirubicin—urinary bladder cancer	0.000168	0.000848	CcSEcCtD
Amlodipine—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000168	0.000846	CcSEcCtD
Amlodipine—Rash—Cisplatin—urinary bladder cancer	0.000167	0.000844	CcSEcCtD
Amlodipine—Dermatitis—Cisplatin—urinary bladder cancer	0.000167	0.000843	CcSEcCtD
Amlodipine—Malnutrition—Epirubicin—urinary bladder cancer	0.000167	0.000842	CcSEcCtD
Amlodipine—Diarrhoea—Etoposide—urinary bladder cancer	0.000166	0.000839	CcSEcCtD
Amlodipine—Nausea—Fluorouracil—urinary bladder cancer	0.000166	0.000839	CcSEcCtD
Amlodipine—Eye disorder—Doxorubicin—urinary bladder cancer	0.000166	0.000837	CcSEcCtD
Amlodipine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000166	0.000835	CcSEcCtD
Amlodipine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000166	0.000835	CcSEcCtD
Amlodipine—Flushing—Doxorubicin—urinary bladder cancer	0.000165	0.000831	CcSEcCtD
Amlodipine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000165	0.000831	CcSEcCtD
Amlodipine—Flatulence—Epirubicin—urinary bladder cancer	0.000165	0.00083	CcSEcCtD
Amlodipine—Tension—Epirubicin—urinary bladder cancer	0.000164	0.000827	CcSEcCtD
Amlodipine—Dysgeusia—Epirubicin—urinary bladder cancer	0.000164	0.000825	CcSEcCtD
Amlodipine—Nervousness—Epirubicin—urinary bladder cancer	0.000162	0.000818	CcSEcCtD
Amlodipine—Back pain—Epirubicin—urinary bladder cancer	0.000162	0.000815	CcSEcCtD
Amlodipine—Angiopathy—Doxorubicin—urinary bladder cancer	0.000161	0.000812	CcSEcCtD
Amlodipine—Malaise—Methotrexate—urinary bladder cancer	0.000161	0.000812	CcSEcCtD
Amlodipine—Dizziness—Etoposide—urinary bladder cancer	0.000161	0.000811	CcSEcCtD
Amlodipine—Muscle spasms—Epirubicin—urinary bladder cancer	0.000161	0.00081	CcSEcCtD
Amlodipine—Immune system disorder—Doxorubicin—urinary bladder cancer	0.00016	0.000809	CcSEcCtD
Amlodipine—Vertigo—Methotrexate—urinary bladder cancer	0.00016	0.000809	CcSEcCtD
Amlodipine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.00016	0.000807	CcSEcCtD
Amlodipine—Leukopenia—Methotrexate—urinary bladder cancer	0.00016	0.000806	CcSEcCtD
Amlodipine—Chills—Doxorubicin—urinary bladder cancer	0.000159	0.000803	CcSEcCtD
Amlodipine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000159	0.0008	CcSEcCtD
Amlodipine—Nausea—Cisplatin—urinary bladder cancer	0.000158	0.000795	CcSEcCtD
Amlodipine—Alopecia—Doxorubicin—urinary bladder cancer	0.000157	0.000791	CcSEcCtD
Amlodipine—Cough—Methotrexate—urinary bladder cancer	0.000156	0.000785	CcSEcCtD
Amlodipine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000156	0.000784	CcSEcCtD
Amlodipine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000155	0.000781	CcSEcCtD
Amlodipine—Vomiting—Etoposide—urinary bladder cancer	0.000155	0.00078	CcSEcCtD
Amlodipine—Malnutrition—Doxorubicin—urinary bladder cancer	0.000155	0.000779	CcSEcCtD
Amlodipine—Agitation—Epirubicin—urinary bladder cancer	0.000154	0.000774	CcSEcCtD
Amlodipine—Rash—Etoposide—urinary bladder cancer	0.000153	0.000773	CcSEcCtD
Amlodipine—Dermatitis—Etoposide—urinary bladder cancer	0.000153	0.000772	CcSEcCtD
Amlodipine—Headache—Etoposide—urinary bladder cancer	0.000152	0.000768	CcSEcCtD
Amlodipine—Flatulence—Doxorubicin—urinary bladder cancer	0.000152	0.000768	CcSEcCtD
Amlodipine—Myalgia—Methotrexate—urinary bladder cancer	0.000152	0.000766	CcSEcCtD
Amlodipine—Chest pain—Methotrexate—urinary bladder cancer	0.000152	0.000766	CcSEcCtD
Amlodipine—Arthralgia—Methotrexate—urinary bladder cancer	0.000152	0.000766	CcSEcCtD
Amlodipine—Tension—Doxorubicin—urinary bladder cancer	0.000152	0.000765	CcSEcCtD
Amlodipine—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000151	0.000763	CcSEcCtD
Amlodipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000151	0.000761	CcSEcCtD
Amlodipine—Malaise—Epirubicin—urinary bladder cancer	0.000151	0.00076	CcSEcCtD
Amlodipine—Discomfort—Methotrexate—urinary bladder cancer	0.00015	0.000757	CcSEcCtD
Amlodipine—Nervousness—Doxorubicin—urinary bladder cancer	0.00015	0.000757	CcSEcCtD
Amlodipine—Vertigo—Epirubicin—urinary bladder cancer	0.00015	0.000757	CcSEcCtD
Amlodipine—Syncope—Epirubicin—urinary bladder cancer	0.00015	0.000755	CcSEcCtD
Amlodipine—Leukopenia—Epirubicin—urinary bladder cancer	0.00015	0.000754	CcSEcCtD
Amlodipine—Back pain—Doxorubicin—urinary bladder cancer	0.00015	0.000754	CcSEcCtD
Amlodipine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000149	0.000749	CcSEcCtD
Amlodipine—Palpitations—Epirubicin—urinary bladder cancer	0.000148	0.000744	CcSEcCtD
Amlodipine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000147	0.00074	CcSEcCtD
Amlodipine—Cough—Epirubicin—urinary bladder cancer	0.000146	0.000735	CcSEcCtD
Amlodipine—Nausea—Etoposide—urinary bladder cancer	0.000145	0.000728	CcSEcCtD
Amlodipine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000143	0.000723	CcSEcCtD
Amlodipine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000143	0.00072	CcSEcCtD
Amlodipine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000143	0.000719	CcSEcCtD
Amlodipine—Myalgia—Epirubicin—urinary bladder cancer	0.000142	0.000717	CcSEcCtD
Amlodipine—Chest pain—Epirubicin—urinary bladder cancer	0.000142	0.000717	CcSEcCtD
Amlodipine—Arthralgia—Epirubicin—urinary bladder cancer	0.000142	0.000717	CcSEcCtD
Amlodipine—Agitation—Doxorubicin—urinary bladder cancer	0.000142	0.000716	CcSEcCtD
Amlodipine—Anxiety—Epirubicin—urinary bladder cancer	0.000142	0.000715	CcSEcCtD
Amlodipine—Skin disorder—Methotrexate—urinary bladder cancer	0.000142	0.000713	CcSEcCtD
Amlodipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000141	0.000712	CcSEcCtD
Amlodipine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000141	0.00071	CcSEcCtD
Amlodipine—Discomfort—Epirubicin—urinary bladder cancer	0.000141	0.000708	CcSEcCtD
Amlodipine—Malaise—Doxorubicin—urinary bladder cancer	0.000139	0.000703	CcSEcCtD
Amlodipine—Dry mouth—Epirubicin—urinary bladder cancer	0.000139	0.000701	CcSEcCtD
Amlodipine—Vertigo—Doxorubicin—urinary bladder cancer	0.000139	0.0007	CcSEcCtD
Amlodipine—Anorexia—Methotrexate—urinary bladder cancer	0.000139	0.0007	CcSEcCtD
Amlodipine—Syncope—Doxorubicin—urinary bladder cancer	0.000139	0.000699	CcSEcCtD
Amlodipine—Leukopenia—Doxorubicin—urinary bladder cancer	0.000138	0.000698	CcSEcCtD
Amlodipine—Palpitations—Doxorubicin—urinary bladder cancer	0.000137	0.000689	CcSEcCtD
Amlodipine—Oedema—Epirubicin—urinary bladder cancer	0.000136	0.000687	CcSEcCtD
Amlodipine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000136	0.000685	CcSEcCtD
Amlodipine—Cough—Doxorubicin—urinary bladder cancer	0.000135	0.00068	CcSEcCtD
Amlodipine—Shock—Epirubicin—urinary bladder cancer	0.000134	0.000676	CcSEcCtD
Amlodipine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000134	0.000674	CcSEcCtD
Amlodipine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000134	0.000673	CcSEcCtD
Amlodipine—Tachycardia—Epirubicin—urinary bladder cancer	0.000133	0.000671	CcSEcCtD
Amlodipine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000133	0.000669	CcSEcCtD
Amlodipine—Skin disorder—Epirubicin—urinary bladder cancer	0.000132	0.000668	CcSEcCtD
Amlodipine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000132	0.000665	CcSEcCtD
Amlodipine—Insomnia—Methotrexate—urinary bladder cancer	0.000132	0.000664	CcSEcCtD
Amlodipine—Chest pain—Doxorubicin—urinary bladder cancer	0.000132	0.000663	CcSEcCtD
Amlodipine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000132	0.000663	CcSEcCtD
Amlodipine—Myalgia—Doxorubicin—urinary bladder cancer	0.000132	0.000663	CcSEcCtD
Amlodipine—Anxiety—Doxorubicin—urinary bladder cancer	0.000131	0.000661	CcSEcCtD
Amlodipine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000131	0.00066	CcSEcCtD
Amlodipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000131	0.000659	CcSEcCtD
Amlodipine—Discomfort—Doxorubicin—urinary bladder cancer	0.00013	0.000656	CcSEcCtD
Amlodipine—Anorexia—Epirubicin—urinary bladder cancer	0.00013	0.000655	CcSEcCtD
Amlodipine—Dyspnoea—Methotrexate—urinary bladder cancer	0.00013	0.000655	CcSEcCtD
Amlodipine—Somnolence—Methotrexate—urinary bladder cancer	0.00013	0.000653	CcSEcCtD
Amlodipine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000129	0.000649	CcSEcCtD
Amlodipine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000128	0.000647	CcSEcCtD
Amlodipine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000127	0.000639	CcSEcCtD
Amlodipine—Oedema—Doxorubicin—urinary bladder cancer	0.000126	0.000636	CcSEcCtD
Amlodipine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000126	0.000634	CcSEcCtD
Amlodipine—Fatigue—Methotrexate—urinary bladder cancer	0.000126	0.000633	CcSEcCtD
Amlodipine—Pain—Methotrexate—urinary bladder cancer	0.000125	0.000628	CcSEcCtD
Amlodipine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000124	0.000626	CcSEcCtD
Amlodipine—Shock—Doxorubicin—urinary bladder cancer	0.000124	0.000626	CcSEcCtD
Amlodipine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000124	0.000624	CcSEcCtD
Amlodipine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000124	0.000623	CcSEcCtD
Amlodipine—Insomnia—Epirubicin—urinary bladder cancer	0.000123	0.000622	CcSEcCtD
Amlodipine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000123	0.000621	CcSEcCtD
Amlodipine—Skin disorder—Doxorubicin—urinary bladder cancer	0.000123	0.000618	CcSEcCtD
Amlodipine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000122	0.000617	CcSEcCtD
Amlodipine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000122	0.000615	CcSEcCtD
Amlodipine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000122	0.000613	CcSEcCtD
Amlodipine—Somnolence—Epirubicin—urinary bladder cancer	0.000121	0.000611	CcSEcCtD
Amlodipine—Anorexia—Doxorubicin—urinary bladder cancer	0.00012	0.000606	CcSEcCtD
Amlodipine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00012	0.000605	CcSEcCtD
Amlodipine—Dyspepsia—Epirubicin—urinary bladder cancer	0.00012	0.000605	CcSEcCtD
Amlodipine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000119	0.000601	CcSEcCtD
Amlodipine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000119	0.000598	CcSEcCtD
Amlodipine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000118	0.000593	CcSEcCtD
Amlodipine—Fatigue—Epirubicin—urinary bladder cancer	0.000118	0.000593	CcSEcCtD
Amlodipine—Constipation—Epirubicin—urinary bladder cancer	0.000117	0.000588	CcSEcCtD
Amlodipine—Pain—Epirubicin—urinary bladder cancer	0.000117	0.000588	CcSEcCtD
Amlodipine—Urticaria—Methotrexate—urinary bladder cancer	0.000116	0.000584	CcSEcCtD
Amlodipine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000115	0.000581	CcSEcCtD
Amlodipine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000115	0.000579	CcSEcCtD
Amlodipine—Insomnia—Doxorubicin—urinary bladder cancer	0.000114	0.000575	CcSEcCtD
Amlodipine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000113	0.000571	CcSEcCtD
Amlodipine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000113	0.000567	CcSEcCtD
Amlodipine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000112	0.000566	CcSEcCtD
Amlodipine—Somnolence—Doxorubicin—urinary bladder cancer	0.000112	0.000565	CcSEcCtD
Amlodipine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000112	0.000562	CcSEcCtD
Amlodipine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000111	0.00056	CcSEcCtD
Amlodipine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.00011	0.000553	CcSEcCtD
Amlodipine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000109	0.000549	CcSEcCtD
Amlodipine—Fatigue—Doxorubicin—urinary bladder cancer	0.000109	0.000548	CcSEcCtD
Amlodipine—Urticaria—Epirubicin—urinary bladder cancer	0.000108	0.000546	CcSEcCtD
Amlodipine—Pain—Doxorubicin—urinary bladder cancer	0.000108	0.000544	CcSEcCtD
Amlodipine—Constipation—Doxorubicin—urinary bladder cancer	0.000108	0.000544	CcSEcCtD
Amlodipine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000108	0.000543	CcSEcCtD
Amlodipine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000107	0.000541	CcSEcCtD
Amlodipine—Asthenia—Methotrexate—urinary bladder cancer	0.000105	0.000527	CcSEcCtD
Amlodipine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000104	0.000524	CcSEcCtD
Amlodipine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000103	0.00052	CcSEcCtD
Amlodipine—Pruritus—Methotrexate—urinary bladder cancer	0.000103	0.00052	CcSEcCtD
Amlodipine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.0001	0.000506	CcSEcCtD
Amlodipine—Urticaria—Doxorubicin—urinary bladder cancer	0.0001	0.000505	CcSEcCtD
Amlodipine—Abdominal pain—Doxorubicin—urinary bladder cancer	9.98e-05	0.000503	CcSEcCtD
Amlodipine—Diarrhoea—Methotrexate—urinary bladder cancer	9.97e-05	0.000503	CcSEcCtD
Amlodipine—Asthenia—Epirubicin—urinary bladder cancer	9.79e-05	0.000493	CcSEcCtD
Amlodipine—Pruritus—Epirubicin—urinary bladder cancer	9.65e-05	0.000486	CcSEcCtD
Amlodipine—Dizziness—Methotrexate—urinary bladder cancer	9.64e-05	0.000486	CcSEcCtD
Amlodipine—Diarrhoea—Epirubicin—urinary bladder cancer	9.33e-05	0.00047	CcSEcCtD
Amlodipine—Hypersensitivity—Doxorubicin—urinary bladder cancer	9.3e-05	0.000469	CcSEcCtD
Amlodipine—Vomiting—Methotrexate—urinary bladder cancer	9.27e-05	0.000467	CcSEcCtD
Amlodipine—Rash—Methotrexate—urinary bladder cancer	9.19e-05	0.000463	CcSEcCtD
Amlodipine—Dermatitis—Methotrexate—urinary bladder cancer	9.18e-05	0.000463	CcSEcCtD
Amlodipine—Headache—Methotrexate—urinary bladder cancer	9.13e-05	0.00046	CcSEcCtD
Amlodipine—Asthenia—Doxorubicin—urinary bladder cancer	9.05e-05	0.000456	CcSEcCtD
Amlodipine—Dizziness—Epirubicin—urinary bladder cancer	9.02e-05	0.000455	CcSEcCtD
Amlodipine—Pruritus—Doxorubicin—urinary bladder cancer	8.93e-05	0.00045	CcSEcCtD
Amlodipine—Vomiting—Epirubicin—urinary bladder cancer	8.67e-05	0.000437	CcSEcCtD
Amlodipine—Nausea—Methotrexate—urinary bladder cancer	8.66e-05	0.000436	CcSEcCtD
Amlodipine—Diarrhoea—Doxorubicin—urinary bladder cancer	8.63e-05	0.000435	CcSEcCtD
Amlodipine—Rash—Epirubicin—urinary bladder cancer	8.6e-05	0.000433	CcSEcCtD
Amlodipine—Dermatitis—Epirubicin—urinary bladder cancer	8.59e-05	0.000433	CcSEcCtD
Amlodipine—Headache—Epirubicin—urinary bladder cancer	8.54e-05	0.000431	CcSEcCtD
Amlodipine—Dizziness—Doxorubicin—urinary bladder cancer	8.35e-05	0.000421	CcSEcCtD
Amlodipine—Nausea—Epirubicin—urinary bladder cancer	8.1e-05	0.000408	CcSEcCtD
Amlodipine—Vomiting—Doxorubicin—urinary bladder cancer	8.02e-05	0.000404	CcSEcCtD
Amlodipine—Rash—Doxorubicin—urinary bladder cancer	7.96e-05	0.000401	CcSEcCtD
Amlodipine—Dermatitis—Doxorubicin—urinary bladder cancer	7.95e-05	0.000401	CcSEcCtD
Amlodipine—Headache—Doxorubicin—urinary bladder cancer	7.91e-05	0.000398	CcSEcCtD
Amlodipine—Nausea—Doxorubicin—urinary bladder cancer	7.5e-05	0.000378	CcSEcCtD
Amlodipine—CACNB2—Metabolism—CREBBP—urinary bladder cancer	2.21e-05	0.000144	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.2e-05	0.000143	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	2.19e-05	0.000142	CbGpPWpGaD
Amlodipine—CACNA1D—Metabolism—PPARG—urinary bladder cancer	2.18e-05	0.000142	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	2.17e-05	0.000141	CbGpPWpGaD
Amlodipine—CACNA1C—Developmental Biology—HRAS—urinary bladder cancer	2.15e-05	0.00014	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	2.14e-05	0.000139	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—NQO1—urinary bladder cancer	2.13e-05	0.000139	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—RRM2—urinary bladder cancer	2.11e-05	0.000138	CbGpPWpGaD
Amlodipine—CA1—Metabolism—PTGS2—urinary bladder cancer	2.09e-05	0.000136	CbGpPWpGaD
Amlodipine—CACNA1D—Metabolism—CREBBP—urinary bladder cancer	2.09e-05	0.000136	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—NAT2—urinary bladder cancer	2.07e-05	0.000135	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—RRM2—urinary bladder cancer	2.07e-05	0.000135	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	2.05e-05	0.000133	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	2.03e-05	0.000132	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	2.03e-05	0.000132	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—TYMP—urinary bladder cancer	2e-05	0.00013	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	1.99e-05	0.00013	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	1.96e-05	0.000128	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—ENO2—urinary bladder cancer	1.96e-05	0.000127	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	1.96e-05	0.000127	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—NQO1—urinary bladder cancer	1.96e-05	0.000127	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—RRM2—urinary bladder cancer	1.95e-05	0.000127	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	1.92e-05	0.000125	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—PPARG—urinary bladder cancer	1.91e-05	0.000125	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	1.91e-05	0.000125	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—ENO2—urinary bladder cancer	1.91e-05	0.000125	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	1.9e-05	0.000124	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	1.88e-05	0.000123	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.87e-05	0.000122	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—TYMP—urinary bladder cancer	1.87e-05	0.000121	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.86e-05	0.000121	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	1.86e-05	0.000121	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—CREBBP—urinary bladder cancer	1.84e-05	0.00012	CbGpPWpGaD
Amlodipine—CA1—Metabolism—PTEN—urinary bladder cancer	1.83e-05	0.000119	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.83e-05	0.000119	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.81e-05	0.000118	CbGpPWpGaD
Amlodipine—CACNB2—Metabolism—PTGS2—urinary bladder cancer	1.81e-05	0.000118	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—HPGDS—urinary bladder cancer	1.81e-05	0.000118	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—ENO2—urinary bladder cancer	1.81e-05	0.000118	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—NAT2—urinary bladder cancer	1.81e-05	0.000118	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.8e-05	0.000117	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.79e-05	0.000117	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—RRM2—urinary bladder cancer	1.79e-05	0.000117	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	1.78e-05	0.000116	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—GSTT1—urinary bladder cancer	1.75e-05	0.000114	CbGpPWpGaD
Amlodipine—CA1—Metabolism—EP300—urinary bladder cancer	1.74e-05	0.000113	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.73e-05	0.000112	CbGpPWpGaD
Amlodipine—CACNA1D—Metabolism—PTGS2—urinary bladder cancer	1.71e-05	0.000112	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	1.7e-05	0.000111	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—NAT2—urinary bladder cancer	1.69e-05	0.00011	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.67e-05	0.000109	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	1.66e-05	0.000108	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—ENO2—urinary bladder cancer	1.66e-05	0.000108	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—TYMS—urinary bladder cancer	1.65e-05	0.000108	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.65e-05	0.000107	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	1.64e-05	0.000106	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	1.64e-05	0.000106	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	1.63e-05	0.000106	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.61e-05	0.000105	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	1.61e-05	0.000105	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.6e-05	0.000104	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	1.59e-05	0.000104	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.58e-05	0.000103	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.58e-05	0.000103	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—NQO1—urinary bladder cancer	1.58e-05	0.000103	CbGpPWpGaD
Amlodipine—CACNB2—Metabolism—PTEN—urinary bladder cancer	1.58e-05	0.000103	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—GPX1—urinary bladder cancer	1.57e-05	0.000102	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.56e-05	0.000102	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—NQO1—urinary bladder cancer	1.54e-05	0.0001	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.54e-05	0.0001	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	1.54e-05	0.0001	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.53e-05	9.97e-05	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—TYMS—urinary bladder cancer	1.52e-05	9.87e-05	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—PTGS2—urinary bladder cancer	1.51e-05	9.8e-05	CbGpPWpGaD
Amlodipine—CACNB2—Metabolism—EP300—urinary bladder cancer	1.5e-05	9.8e-05	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	1.5e-05	9.76e-05	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	1.5e-05	9.76e-05	CbGpPWpGaD
Amlodipine—CACNA1D—Metabolism—PTEN—urinary bladder cancer	1.49e-05	9.73e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	1.47e-05	9.57e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—NQO1—urinary bladder cancer	1.46e-05	9.49e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1.46e-05	9.48e-05	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	1.44e-05	9.41e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.44e-05	9.4e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.44e-05	9.4e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	1.44e-05	9.39e-05	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—GPX1—urinary bladder cancer	1.44e-05	9.35e-05	CbGpPWpGaD
Amlodipine—CACNA1D—Metabolism—EP300—urinary bladder cancer	1.42e-05	9.28e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.41e-05	9.2e-05	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	1.41e-05	9.18e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.4e-05	9.12e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	1.36e-05	8.86e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	1.36e-05	8.86e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.35e-05	8.78e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.35e-05	8.78e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.34e-05	8.73e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—NQO1—urinary bladder cancer	1.34e-05	8.7e-05	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	1.32e-05	8.63e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	1.32e-05	8.59e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	1.32e-05	8.57e-05	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—PTEN—urinary bladder cancer	1.31e-05	8.55e-05	CbGpPWpGaD
Amlodipine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.31e-05	8.54e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.31e-05	8.52e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.3e-05	8.44e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.29e-05	8.39e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	1.29e-05	8.38e-05	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—EP300—urinary bladder cancer	1.25e-05	8.15e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	1.24e-05	8.1e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.23e-05	8.03e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.23e-05	8.01e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—TYMS—urinary bladder cancer	1.22e-05	7.97e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	1.22e-05	7.91e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	1.21e-05	7.87e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	1.21e-05	7.87e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—TYMS—urinary bladder cancer	1.2e-05	7.79e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	1.18e-05	7.7e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	1.18e-05	7.7e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.18e-05	7.66e-05	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—PPARG—urinary bladder cancer	1.17e-05	7.63e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.16e-05	7.58e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—GPX1—urinary bladder cancer	1.16e-05	7.54e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	1.15e-05	7.5e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	1.15e-05	7.5e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.15e-05	7.46e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	1.14e-05	7.4e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—GPX1—urinary bladder cancer	1.13e-05	7.37e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.13e-05	7.36e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—TYMS—urinary bladder cancer	1.13e-05	7.36e-05	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	1.13e-05	7.33e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.12e-05	7.28e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	1.12e-05	7.27e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	1.12e-05	7.27e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	1.11e-05	7.25e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.11e-05	7.24e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	1.11e-05	7.24e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.1e-05	7.17e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.1e-05	7.14e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.09e-05	7.08e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.08e-05	7.02e-05	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—PPARG—urinary bladder cancer	1.07e-05	6.99e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—GPX1—urinary bladder cancer	1.07e-05	6.96e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	1.07e-05	6.96e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.05e-05	6.87e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	1.05e-05	6.84e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	1.04e-05	6.8e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—TYMS—urinary bladder cancer	1.04e-05	6.74e-05	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	1.03e-05	6.72e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	1.02e-05	6.67e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	1.02e-05	6.67e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	9.87e-06	6.43e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—GPX1—urinary bladder cancer	9.8e-06	6.38e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	9.71e-06	6.32e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	9.62e-06	6.27e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	9.6e-06	6.25e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	9.29e-06	6.05e-05	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	9.22e-06	6e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	9.2e-06	5.99e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	9.15e-06	5.96e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	9.07e-06	5.9e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	9.05e-06	5.89e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—TYMS—urinary bladder cancer	9.02e-06	5.88e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	9.01e-06	5.87e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	8.92e-06	5.81e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	8.92e-06	5.81e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	8.89e-06	5.79e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	8.89e-06	5.79e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.77e-06	5.71e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—PPARG—urinary bladder cancer	8.67e-06	5.64e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	8.63e-06	5.62e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—GPX1—urinary bladder cancer	8.54e-06	5.56e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	8.5e-06	5.54e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—PPARG—urinary bladder cancer	8.47e-06	5.52e-05	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	8.45e-06	5.5e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—TYMS—urinary bladder cancer	8.43e-06	5.49e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	8.4e-06	5.47e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	8.4e-06	5.47e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	8.39e-06	5.46e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	8.33e-06	5.43e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	8.33e-06	5.43e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	8.32e-06	5.42e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	8.14e-06	5.3e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	8.05e-06	5.24e-05	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—PTEN—urinary bladder cancer	8.04e-06	5.23e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—PPARG—urinary bladder cancer	8e-06	5.21e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—GPX1—urinary bladder cancer	7.98e-06	5.2e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	7.9e-06	5.15e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	7.88e-06	5.13e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.86e-06	5.12e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	7.83e-06	5.1e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	7.75e-06	5.05e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	7.69e-06	5.01e-05	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—EP300—urinary bladder cancer	7.67e-06	4.99e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.5e-06	4.88e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	7.43e-06	4.84e-05	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—PTEN—urinary bladder cancer	7.37e-06	4.8e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	7.36e-06	4.8e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—PPARG—urinary bladder cancer	7.34e-06	4.78e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	7.2e-06	4.69e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	7.17e-06	4.67e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	7.12e-06	4.64e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	7.12e-06	4.64e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	7.05e-06	4.59e-05	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—EP300—urinary bladder cancer	7.03e-06	4.58e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	6.82e-06	4.44e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	6.82e-06	4.44e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	6.69e-06	4.36e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	6.66e-06	4.34e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—PPARG—urinary bladder cancer	6.39e-06	4.16e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	6.29e-06	4.1e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	6.29e-06	4.1e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	6.14e-06	4e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	6.02e-06	3.92e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	5.98e-06	3.89e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	5.97e-06	3.89e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—PTEN—urinary bladder cancer	5.94e-06	3.87e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—PTEN—urinary bladder cancer	5.81e-06	3.78e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	5.79e-06	3.77e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	5.77e-06	3.76e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	5.74e-06	3.74e-05	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—EP300—urinary bladder cancer	5.67e-06	3.69e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	5.56e-06	3.62e-05	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—EP300—urinary bladder cancer	5.54e-06	3.61e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	5.49e-06	3.58e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	5.49e-06	3.58e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—PTEN—urinary bladder cancer	5.49e-06	3.58e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	5.26e-06	3.43e-05	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—EP300—urinary bladder cancer	5.24e-06	3.41e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	5.17e-06	3.36e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	5.1e-06	3.32e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—PTEN—urinary bladder cancer	5.03e-06	3.28e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	5.03e-06	3.27e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	4.9e-06	3.19e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	4.86e-06	3.16e-05	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—EP300—urinary bladder cancer	4.8e-06	3.13e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	4.74e-06	3.09e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	4.7e-06	3.06e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—PTEN—urinary bladder cancer	4.38e-06	2.86e-05	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—EP300—urinary bladder cancer	4.18e-06	2.72e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	4.13e-06	2.69e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	4.1e-06	2.67e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	4.01e-06	2.61e-05	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—EP300—urinary bladder cancer	3.94e-06	2.57e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	3.94e-06	2.56e-05	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—EP300—urinary bladder cancer	3.91e-06	2.54e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	3.78e-06	2.46e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	3.5e-06	2.28e-05	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—EP300—urinary bladder cancer	3.34e-06	2.17e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	3.1e-06	2.02e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.7e-06	1.76e-05	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.58e-06	1.68e-05	CbGpPWpGaD
